Bank of Montreal
NTGN

Bank of Montreal’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Bank of Montreal’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,078
Closed -$4K – 5058
2019
Q4 		$4K Buy
3,078
+1,832
+147% +$2.93K ﹤0.01% 4741
2019
Q3 		$2K Buy
1,246
+59
+5% +$180 ﹤0.01% 4661
2019
Q2 		$6K Buy
1,187
+909
+327% +$5.09K ﹤0.01% 4665
2019
Q1 		$2K Buy
278
+187
+205% +$979 ﹤0.01% 4185
2018
Q4 		$0 Buy
91
+47
+107% +$329 ﹤0.01% 4950
2018
Q3 		$0 Buy
+44
New +$488 ﹤0.01% 4980

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's NTGN Position: Q1 2020 in Review

Bank of Montreal sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q1 2020, closing a stake of 3,078 shares — an estimated $4K sold.

Bank of Montreal first reported a position in NTGN in Q3 2018 and held it in 6 quarters. The position peaked at $6K in Q2 2019. 43 funds tracked by Wall St. Rank hold NTGN as of Q1 2020.

  • Bank of Montreal reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Bank of Montreal sold 3,078 Neon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $4K.
  • Bank of Montreal first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 6 quarters.
  • Bank of Montreal's Neon Therapeutics, Inc. Common Stock position peaked at $6K in Q2 2019.
  • 43 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.